Women's Health
MR Imaging Biomarkers

Women’s Health

Women’s Health Quantitative MR Imaging, Early Detection, Malignancy Probability Mapping Women Health with Optimized MRI Biomarkers

Implementing precise and advanced MR imaging and using imaging biomarkers can be helpful for diagnosis of breast and female genital cancers, malignancy probability mapping of the tumors and early detection of these diseases in primary stages.

Our Diagnostic and Treatment Services In Women’s Health include advanced Quantitative MR analysis:

  • Multi b-value diffusion weighted imaging (intra-voxel incoherent motion imaging (IVIM)) : Simultaneous quantification of perfusion and diffusion parameters
  • DCE MRI: Quantification of perfusion and permeability
  • Magnetic Resonance Spectroscopy (MRS): Analysis of tissue metabolism
  • Radiomic analysis: Characterizing lesion heterogeneity, shape, volume, etc.
  • Tissue Relaxometry (T1 and T2 Mapping): Quantification of relaxometry maps for generation of malignancy maps

Diseases:

  • Breast Cancer
  • Ovarian Cancer

POST-PROCESS

  • Enhancement computation
  • Wash-out computation
  • ADC computation
  • Automatic mapping

QUANTIFY

  • Volume and measures
  • Enhancement histogram
  • Kinetics repartition

COLLABORATE

  • Standardized reports
  • Easy data sharing

ADVANCED

  • Texture
  • IVIM computation
  • DCE computation
  • Kurtosis computation
  • MRS